Arthurian Life Sciences Ltd was established by Europe’s leading biotech entrepreneur Professor Sir Chris Evans OBE to act as General Partner of the Wales Life Sciences Investment Fund, a £100 million fund and key part of the Welsh Government’s Life Sciences initiative.
Arthurian Life Sciences Ltd will deliver the expectations of the Welsh Government in further developing a successful, vibrant, growing, profitable and socially meaningful Life Sciences sector in Wales.
The Arthurian team has been specially assembled to make a major difference and generate a real excitement within Welsh Life Sciences both domestically and internationally.The Fund had its first closing with £50 million on 28th February 2013.
Wales Life Sciences Investment Fund
The Fund will invest in Life Sciences and related medical, pharmaceutical and healthcare companies currently based in Wales, and also in companies from across the UK, Europe and the rest of the world, where such investment will bring meaningful developmental and economic benefit to Wales.
The Fund will make initial investments of between £500,000 and £5,000,000, and will preserve capital to provide follow-on investments. Larger investments may be considered in consultation with the Welsh Government.
Arthurian will spread investments by risk, sub-sector, age or funding requirement and will consider companies of all sizes, both start-ups and mature companies, and will do both early & late stage investments.